

          -  Known allergy to (components of) the BCG vaccine or serious adverse events to prior
             BCG administration

          -  Known active or latent Mycobacterium tuberculosis or with another mycobacterial
             species. A history with- or a suspicion of M. tuberculosis infection.

          -  Fever (>38 C) within the past 24 hours

          -  Age > 75 years

          -  Pregnancy or planning pregnancy within 30 days of study enrollment

          -  Breastfeeding

          -  Suspicion of active viral or bacterial infection

          -  Any Immunocompromised subjects. This exclusion category comprises: a) subjects with
             known infection by the human immunodeficiency virus (HIV-1); b) subjects with known
             neutropenic with less than 1500 neutrophils/mm3; c) subjects with solid organ
             transplantation; d) subjects with bone marrow transplantation; e) subjects under
             chemotherapy; f) subjects with primary immunodeficiency; g) known severe lymphopenia
             with less than 400 lymphocytes/mm3; h) treatment with any anti-cytokine therapies. i)
             treatment with oral or intravenous steroids defined as daily doses of 10mg prednisone
             or equivalent for longer than 3 months

          -  Living with someone who is immunosuppressed or taking immunosuppressive drugs

          -  Previous documented infection with COVID19

          -  Active solid or non-solid malignancy or lymphoma within the prior two years

          -  Direct involvement in the design or the execution of the study

          -  Expected absence from work of >=4 of the following 12 weeks due to any reason
             (holidays, maternity leave, retirement, planned surgery etc)

          -  Not in possession of a smartphone

          -  Inability to keep the vaccine site covered in the case of a draining pustule.
      